Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

BI 1819479

Status:

Phase 2

Condition:

Idiopathic Pulmonary Fibrosis

Intervention Type:

Oral Drug

Funder Type:

Industry

Drug Details

BI 1819479 is a lysophospholipase inhibitor.

Study Purpose

The purpose of this study is to find out whether a medicine called BI 1819479 helps people with idiopathic pulmonary fibrosis (IPF). Three different doses of BI 1819479 are tested in this study.

Find a Clinical Trial